Physicists at Paderborn University have, for the first time, experimentally demonstrated the so-called ‘return’ of Rabi oscillations in semiconductor quantum dots. The phenomenon, which was first predicted theoretically back in 2007, describes the decrease in the emission intensity of the quantum dots, which are initially dampened by interactions with the lattice vibrations of a solid (phonons). Only through sufficiently strong optical excitation can the original intensity be restored and the oscillation ‘reawaken’: an effect that previously existed only in idealised theoretical models and has now been proven. The results, published in the prestigious journal *Physical Review Letters*, mark a decisive step towards scalable quantum applications.

Restoring blood flow can save tissue after heart attack, stroke, transplantation, and severe injury, but it can also trigger a damaging second wave.

A team led by Professor Wei Yang at the National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, has developed a computational-experimental pipeline that synergistically optimizes antibody framework regions (FR) and complementarity-determining regions (CDR). Using this approach, they engineered two pan-Ebola antibodies with markedly improved neutralization breadth and potency. The study, titled “Computational Design of Broad-Spectrum Ebola Antibodies through Framework and Complementarity-Determining Regions Synergistic Optimization” is published in Research.

University of Phoenix College of Doctoral Studies scholars Pamayla E. Darbyshire, DHA, MSN/CNS, and Carl Beitsayadeh, MS, have published the article, “Enhancing Student Success through GAI and Predictive Analytics,” in International Journal for Educational Media and Technology. The conceptual paper proposes a theoretically grounded 16-stage framework for integrating generative artificial intelligence and predictive analytics into a unified, closed-loop support system for online higher education.

DENVER - Researchers at National Jewish Health have uncovered a previously unknown mechanism that helps drive inflammation in allergic asthma, offering new insight into how the disease develops and potentially revealing new targets for future therapies.